drugset / Trial / NCT01103206

Evaluation of a Cincalcet Suppression Test

NCT01103206

RandomizedCrossoverOpen-labelDiagnostic

Summary

The aim of the study is to compare the results of a parathyroid hormone (PTH)suppression test using a single oral tablet of cinacalcet in two groups of subjects: 1- a group of healthy adults in whom the results of the test with cinacalcet will be compared with those of the standardized PTH suppression test with intravenous calcium loading; 2- a group of patients with proven primary hyperparathyroidism in whom the results of the test with cinacalcet will be compared with those obtained during the same test, in healthy controls.

Timeline

Start
2010-04
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinacalcet Other / unclassified 30 mg Oral
Subject Cinacalcet Other / unclassified 60 mg Oral

Indications

No indication recorded.